Research Articles | Page 29 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Towards graft- versus-host disease-free alternative donor transplant platforms for patients with acquired aplastic anemia May 2025 Haematologica Aplastic Anemia, Graft Versus Host Disease (GVHD)
Danicopan: an oral complement factor D inhibitor for paroxysmal nocturnal hemoglobinuria Oct 2020 Haematologica Paroxysmal Nocturnal Hemoglobinuria (PNH)
Predicting response of severe aplastic anemia to immunosuppression combined with eltrombopag Apr 2021 Haematologica Aplastic Anemia
Diagnosis of myelodysplastic syndromes: the classic and the novel Oct 2024 Haematologica Myelodysplastic Syndromes (MDS)
Use of Immunosuppressive therapy for management of myelodysplastic syndromes: a systematic review and meta-analysis Apr 2019 Haemotologica Myelodysplastic Syndromes (MDS)
Thrombosis at Unusual Sites: Focus on Myeloproliferative Neoplasms and Paroxysmal Nocturnal Hemoglobinuria Feb 2025 Hamostaseologie Myeloproliferative Neoplasms (MPN), Paroxysmal Nocturnal Hemoglobinuria (PNH)
Thrombosis at Unusual Sites: Focus on Myeloproliferative Neoplasms and Paroxysmal Nocturnal Hemoglobinuria Apr 2025 Hamostaseologie Myeloproliferative Neoplasms (MPN), Paroxysmal Nocturnal Hemoglobinuria (PNH)
Childhood myelodysplastic syndromes: Is cytoreductive therapy useful before allogeneic hematopoietic stem cell transplantation? Jul 2024 HemaSphere Myelodysplastic Syndromes (MDS)
Toward a more patient-centered drug development process in clinical trials for patients with myelodysplastic syndromes/neoplasms (MDS): Practical considerations from the International Consortium for MDS (icMDS) May 2024 HemaSphere Myelodysplastic Syndromes (MDS)
Controversies on the Consequences of Iron Overload and Chelation in MDS May 2020 HemaSphere Myelodysplastic Syndromes (MDS)